The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Regurin 20mg coated Tablets

20 milligram(s) Coated tablet

Imbat LimitedPPA1151/038/001

Main Information

Trade NameRegurin 20mg coated Tablets
Active SubstancesTrospium chloride
Strength20 milligram(s)
Dosage FormCoated tablet
Licence HolderImbat Limited
Licence NumberPPA1151/038/001

Group Information

ATC CodeA03DA Synthetic anticholinergic agents in combination with analgesics
A03DA06 trospium and analgesics


Licence Issued23/11/2007
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back